Amedisys Inc (AMED)
Debt-to-equity ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 361,900 | 366,900 | 369,900 | 373,200 | 419,400 | 443,400 | 442,400 | 429,500 | 432,100 | 434,800 | 179,400 | 231,400 | 204,500 | 300,600 | 392,700 | 379,900 | 232,256 | 231,600 | 266,500 | 303,700 |
| Total stockholders’ equity | US$ in thousands | 1,066,510 | 1,039,910 | 1,006,780 | 1,079,120 | 1,051,570 | 1,015,740 | 985,646 | 966,758 | 931,351 | 905,264 | 874,272 | 788,153 | 809,224 | 756,205 | 720,851 | 679,197 | 640,450 | 602,564 | 561,781 | 520,246 |
| Debt-to-equity ratio | 0.34 | 0.35 | 0.37 | 0.35 | 0.40 | 0.44 | 0.45 | 0.44 | 0.46 | 0.48 | 0.21 | 0.29 | 0.25 | 0.40 | 0.54 | 0.56 | 0.36 | 0.38 | 0.47 | 0.58 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $361,900K ÷ $1,066,510K
= 0.34
Amedisys Inc.'s debt-to-equity ratio has shown some fluctuations over the past eight quarters. The ratio ranged from 0.37 to 0.46 during this period. A decreasing trend is observed from Q4 2022 to Q1 2023, where the ratio decreased from 0.41 to 0.37. However, there was a slight increase in the ratio in Q2 and Q3 2023, reaching 0.40 and 0.39, respectively.
Overall, the debt-to-equity ratio for Amedisys Inc. has stayed within a relatively narrow range, indicating a conservative level of financial leverage. A lower ratio suggests that the company relies more on equity financing rather than debt to fund its operations and growth. It is essential for investors and analysts to continue monitoring this ratio to assess the company's capital structure and financial risk.
Peer comparison
Dec 31, 2023